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Objectives
The reporting of randomised controlled trials (RCTs)
has improved since the publication of the first CON-
SORT statement. However, word limitations on journal
articles still preclude full description of methodology.
The extended format of HTA monographs enable trial-
ists to fully articulate methods. We assess the impact of
the lack of reference to missing data in CONSORT on
the reporting of RCTs in HTA monographs and com-
pare with randomisation, blinding, and allocation con-
cealment which are included.
Methods
The methodology for the comparison for the randomi-
sation, blinding and allocation concealment followed
the structure used by Hopewell et al. when assessing
the impact of the updates of CONSORT. Detail of
these on methodological CONSORT items were
extracted for each monograph identified using a 1996
and 2001 CONSORT item check list for the periods
1997-2001, 2002-2005 and 2006-2010 respectively.
Screening and data extraction was carried out indepen-
dently by two authors determining whether each item
was reported. Any discrepancies were referred to the
other authors and resolved through discussion and
consensus. We extended this methodology for whether
missing data occurred and was described, and whether
imputation and a sensitivity analysis were used. Addi-
tionally the methods of treatment of missing data were
recorded.
Results
We identified 517 monographs which yielded 93 parallel
group, crossover, cluster, factorial and cost-effectiveness
RCTs for assessment. Across the three periods randomi-
sation reporting increased from 70% to 92%, allocation
concealment from 70% to 90% while blinding varied
between 70% and 83%. Missing data issues were rarely
discussed in a missing data section. Some details could
be identified by careful reading of methods section,
however the details of imputation methods used were
only rose from 40% to 71%. The details of a sensitivity
analysis are only reported in 30% of studies.
Conclusions
Most topics examined were more frequently reported in
recent years, however missing values information is still
not present in one quarter of RCT reports, and is more
poorly reported than items specifically listed in CON-
SORT. We often experienced difficulty in establishing
which methodology was used and whether the statistical
and health economics analyses used the same methods.
We recommend that missing data be included within
the CONSORT checklist to improve the reporting of an
important element of trial analysis.
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